Balyasny Asset Management LLC Inovio Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.38 - $0.58 $25,819 - $39,408	-67,945 Reduced 78.8%	18,283 $7,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $33,628 - $81,054	86,228 New	86,228 $38,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $23,503 - $41,672	-16,669 Reduced 25.52%	48,660 $75,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $14,682 - $24,677	8,845 Added 15.66%	65,329 $113,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $81,336 - $224,806	56,484 New	56,484 $98,000
Q2 2020 Aug 14, 2020	SELL	$7.14 - $31.69 $2.38 Million - $10.6 Million	-333,487 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $993,791 - $4.7 Million	333,487 New	333,487 $2.48 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $499M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.